📣Congratulations SetPoint Medical on a new round of financing to support pivotal trial in patients with #RA. Josh Makower, MD and the NEA team are proud to support! globenewswire.com/news-release/2…

Feds should option next tranche of J&J vaccine; as hedge against need for supply and in anticipation that J&J jab could turn into 2-dose vaccine or patients may opt for boosters after 2-dose data is revealed. If we have excess we can donate, starting with sharing more with Mexico

🎉In today's ambiguous acronym news, NEA's own Josh Makower has been elected to the NAE--one of the highest honors accorded an engineer! Investor, inventor, founder, author... we're just glad to call endlessly talented Josh Makower, MD our partner & friend. bit.ly/3aMwOHm

CONGRATULATIONS and welcome back Josh Makower, MD! We're excited to welcome you as the new director of Stanford Biodesign starting August 1. More details in a news story coming tomorrow, stay tuned! Josh Makower Josh Makower #healthtech #innovation #training

“Hearing that Josh was interested in the director position was like finding out Steph Curry is eligible to play on your college basketball team. We're delighted to welcome him back to Stanford Biodesign.” Paul Yock Josh Makower, MD Josh Makower Josh Makower med.stanford.edu/news/all-news/…

We're always proud of Josh Makower, MD and his dedication to developing new tech to advance patient care. We're excited to continue building companies together as he assumes leadership of the Stanford Biodesign program he co-founded more than 20yrs ago. Congrats Josh! nea.com/blog/many-path…

Learn why staying focused on the need and the customer leads to the next big innovative idea, what's wrong with reimbursement, and a new #healthtech policy focus for Stanford Biodesign in DeviceTalks with Josh Makower, MD! TomS Chris Newmarker Josh Makower devicetalks.com/makower-making…

Congratulations to Josh Makower, the new director of Stanford Biodesign. Earlier this summer, he spoke with David Cassak | Expert MedTech Insight & Analysis about his plans for the center. Read the MedTech Strategist | MedTech's Most Trusted Source interview here (free). bit.ly/2WSFtog

“One of the greatest thrills in life is to do something that's never been done before. It’s about breaking new ground and improving outcomes for patients.” Watch the 1st #MedTechTrailblazers episode with Josh Makower, MD, incoming director of Stanford Biodesign: youtube.com/watch?v=Gklz59…

Tune in to this week’s podcast as Josh Makower, MD, incoming director of Stanford Biodesign, talks about his journey from MIT and medical school to becoming a quintessential #entrepreneur: megaphone.link/OSC3214223663 #medtech NEA

Don't miss part 2! Fogarty Innovation CEO Andrew Cleeland interviews Josh Makower, MD, an engineer, physician, serial medtech entrepreneur, venture capitalist, musician, artist, wine connoisseur, and the new director of Stanford Biodesign. #medtechtrailblazers youtube.com/watch?v=TRdAGx…

Tune in to part 2 of our podcast with Josh Makower, MD, as he discusses his experience working at Pfizer, breaking new ground by launching @ExploraMed and coming full circle as co-founder and now director of Stanford Biodesign. Listen to the podcast: medtechtrailblazers.libsyn.com

Biodesign 2.0 Offsite! With creative help from Paulo Simas, we gathered at Casa Josh Makower, MD to revisit our purpose by examining the problems we are trying to solve, the three things we do daily to achieve those goals, and how we define our relevance, reach, and results.

Still Trust will play The Bitter End in NYC on Saturday November 13th, 2021 at 8pm. First time we've been together since the pandemic cancelled our last performance in March 2020. All are welcome - proof of vaccination required for admission.

My Band, Still Trust, will play Bitter End on Saturday, June 11th at 9 PM. Buy your tickets now to get preferred seating here: bitterend.com/#/events?event…

Ready to invent your future? Applications for the 2023-24 Stanford Biodesign Innovation Fellowship are now OPEN! Learn more about this once in a lifetime opportunity here: biodesign.stanford.edu/programs/fello… #healthteach #innovation #training”

Joe Knight, President and CEO of InnAVasc cites his Biodesign Innovation Fellowship as the foundation and the core of his career. “I am a better innovator and executive because of the time spent at Stanford Biodesign. Gore recentally acquired InnAVasc Medical, Inc.

At the 24th Annual Thomas J. Fogarty, MD Lecture, Mir Imran shared lessons from his 40-year career developing breakthrough health innovations that have helped millions of people. Thank you Stanford Surgery and Fogarty Innovation for supporting this program with us!

My band, Still Trust, has just released our first live album! Available now on all the major streaming platforms: lnkd.in/gcX2vwDr We'll be performing next at The Bitter End in NYC on April 29th, 2023 at 9:30PM. Tickets are available now at: lnkd.in/gSu_UVTH